Search by Drug Name or NDC
NDC 51662-1201-01 Adenosine Injection, 6mg/2mL (3mg/mL) Vial 3 mg/mL Details
Adenosine Injection, 6mg/2mL (3mg/mL) Vial 3 mg/mL
Adenosine Injection, 6mg/2mL (3mg/mL) Vial is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by HF Acquisition Co. LLC, DBA Health First. The primary component is ADENOSINE.
Product Information
| NDC | 51662-1201 |
|---|---|
| Product ID | 51662-1201_075fc2cd-3b45-c167-e063-6294a90a76a2 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Adenosine Injection, 6mg/2mL (3mg/mL) Vial |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Adenosine Injection, 6mg/2mL (3mg/mL) Vial |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 3 |
| Active Ingredient Units | mg/mL |
| Substance Name | ADENOSINE |
| Labeler Name | HF Acquisition Co. LLC, DBA Health First |
| Pharmaceutical Class | Adenosine Receptor Agonist [EPC], Adenosine Receptor Agonists [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA078076 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51662-1201-01 (51662120101)
| NDC Package Code | 51662-1201-1 |
|---|---|
| Billing NDC | 51662120101 |
| Package | 2 mL in 1 VIAL (51662-1201-1) |
| Marketing Start Date | 2018-07-14 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |